This inventor holds 2 USPTO granted patents and 20 published patent applications. Top assignee: Bolt Biotherapeutics, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Matthew Zhou
Introduction
Matthew Zhou is an accomplished inventor based in Redwood City, CA. He has made significant strides in the field of biotherapeutics, particularly with his work on macromolecule-supported compounds. His innovative approach has the potential to impact cancer treatment significantly.
Latest Patents
Matthew Zhou holds a patent for macromolecule-supported aminobenzazepine compounds. The patent application provides macromolecule-supported compounds of Formula I or III, which comprise a macromolecular support linked by conjugation to one or more aminobenzazepine derivatives. Additionally, it includes aminobenzazepine derivative intermediate compositions of Formula II that contain a reactive functional group. These intermediate compositions serve as suitable substrates for the formation of macromolecule-supported compounds through a linker or linking moiety. The application also details compositions that include the macromolecule-supported compounds and methods for treating cancer using these compounds. He has 1 patent to his name.
Career Highlights
Matthew Zhou is currently employed at Bolt Biotherapeutics, Inc., where he continues to develop innovative solutions in the biotherapeutics sector. His work focuses on creating advanced compounds that can lead to more effective cancer treatments.
Collaborations
One of his notable coworkers is Michael N Alonso, with whom he collaborates on various projects within the company.
Conclusion
Matthew Zhou's contributions to the field of biotherapeutics, particularly through his patent on macromolecule-supported aminobenzazepine compounds, showcase his innovative spirit and dedication to improving cancer treatment. His work at Bolt Biotherapeutics, Inc. positions him as a key player in the ongoing fight against cancer.